Viking Therapeutics
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
VKTX Key Statistics
Stock Snapshot
The current Viking Therapeutics(VKTX) stock price is $37.05, with a market capitalization of 4.16B. The stock trades at a price-to-earnings (P/E) ratio of -17.36.
On 2025-11-08, Viking Therapeutics(VKTX) stock traded between a low of $34.68 and a high of $37.51. Shares are currently priced at $37.05, which is +6.8% above the low and -1.2% below the high.
Viking Therapeutics(VKTX) shares are trading with a volume of 4.65M, against a daily average of 4.61M.
During the past year, Viking Therapeutics(VKTX) stock moved between $18.92 at its lowest and $70.41 at its peak.
During the past year, Viking Therapeutics(VKTX) stock moved between $18.92 at its lowest and $70.41 at its peak.
VKTX News
Viking Therapeutics (VKTX) announced that new clinical data from the company’s VK2735 obesity program were highlighted in a poster presentation at ObesityWeek 2...
Viking Therapeutics announced it will present new clinical data on its dual GLP-1/GIP agonist VK2735, currently under evaluation in both injectable and oral for...
